The US Food & Drug Administration (USFDA) has given its first supplemental abbreviated new drug applications (ANDA) approval, to the Glenmark Pharma’s manufacturing facility in Monroe, North...
Glenmark Pharmaceuticals has submitted a new drug application for its nasal spray Ryaltris, with the US health regulator. In a BSE filing the company stated,...
Glenmark Pharma has received final approval for Colesevelam Hydrochloride tablets, 625 mg, the generic version of Daiichi Sankyo’s Welchol tablets, 625 mg, from the US...
Glenmark Pharmaceuticals has received final approval for the generic version of Temovate cream used to treat inflammation and itching caused by a number of skin conditions,...
Glenmark Pharma’s, Baddi manufacturing unit has received 7 observations, from the US health regulator after an audit. Its Baddi unit contributes approx 10% of the revenue...
Glenmark Pharmaceuticals, receives final approval from the US health regulator for Desonide lotion which is used for skin rashes and irritation. In a regulatory filing...
Glenmark Pharmaceuticals has got the US health regulator’s final approval for generic version of Desonide cream that is used in treating a variety of skin...
Glenmark Pharmaceuticals has launched ‘Digihaler’, which will be the country’s first digital dose inhaler (DDI), for asthma and chronic obstructive pulmonary disease patients. The firm...
Three observations have been received by Glenmark Pharmaceuticals from the US health regulator for its Pithampur, Indore plant. The company, however said that it has...
On Thursday, Glenmark Pharma said that it has got USFDA’s final approval for manufacturing and marketing Potassium Chloride extended release capsules and oral contraceptive Norethindrone...